Alembic Pharmaceuticals vs Lupin vs FDC Limited: Which Stock Should You Track
- September 25, 2026
- Posted by: Ankit Jaiswal
- Category: Market
Alembic Pharmaceuticals PE 24.22, mkt cap Rs 16,698 crore. Lupin PE 17.28, mkt cap Rs 95,939 crore. FDC Limited PE 19.23, mkt cap Rs 5,627 crore.
Quick Answer
Alembic Pharmaceuticals vs Lupin vs FDC Limited is a side-by-side comparison of three companies from the Pharma Formulations (Fourth Fresh Set) space. On this comparison, Alembic Pharmaceuticals carries a market capitalisation of about Rs 16,698 crore against Rs 95,939 crore for Lupin and Rs 5,627 crore for FDC Limited, with return on equity of 11.89%, 23.76% and 11.32% respectively. Each company’s numbers are presented here without a declared better pick, since the right stock depends on an investor’s own criteria.
Alembic Pharmaceuticals vs Lupin vs FDC Limited starts with the core numbers most investors compare within the Pharma Formulations (Fourth Fresh Set) segment: market capitalisation, valuation multiples, profitability and dividend yield. Figures below are sourced as of September 2026 and will shift with daily price moves.
All three names sit in the Pharma Formulations (Fourth Fresh Set) bucket, which makes them a natural set to place side by side rather than a random trio of unrelated businesses.
Click Here – Get Free Investment Predictions
Alembic Pharmaceuticals, Lupin and FDC Limited: Company Overview
Alembic Pharmaceuticals is a listed Indian company in the Pharma Formulations (Fourth Fresh Set) space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.
Lupin is a listed Indian company in the Pharma Formulations (Fourth Fresh Set) space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.
FDC Limited is a listed Indian company in the Pharma Formulations (Fourth Fresh Set) space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.
Alembic Pharmaceuticals vs Lupin vs FDC Limited: Valuation and Profitability Snapshot
| Metric | Alembic Pharmaceuticals | Lupin | FDC Limited |
|---|---|---|---|
| Market Cap (approx.) | Rs 16,698 crore | Rs 95,939 crore | Rs 5,627 crore |
| PE Ratio (TTM) | 24.22 | 17.28 | 19.23 |
| PB Ratio | 2.94 | 4.27 | 2.26 |
| Return on Equity (ROE) | 11.89% | 23.76% | 11.32% |
| EPS (TTM, Rs) | 35.08 | 121.39 | 17.97 |
| Dividend Yield | 1.41% | 0.86% | 1.45% |
| Debt to Equity | 0.25 | 0.29 | 0.01 |
| Book Value per Share (Rs) | 288.70 | 490.90 | 152.64 |
Check the Univest Screener for Live Data
On valuation, Alembic Pharmaceuticals trades at a PE of 24.22 and a PB of 2.94, Lupin at a PE of 17.28 and a PB of 4.27, while FDC Limited trades at a PE of 19.23 and a PB of 2.26. On return on equity, the three post 11.89%, 23.76% and 11.32% respectively, and on dividend yield they stand at 1.41%, 0.86% and 1.45%.
Alembic Pharmaceuticals vs Lupin vs FDC Limited: Latest Quarterly Results
| Company | Latest Quarter Revenue | Latest Quarter Net Profit | YoY Change (Revenue) | QoQ Change (Revenue) |
|---|---|---|---|---|
| Alembic Pharmaceuticals | Rs 2,164.70 crore | Rs 172.36 crore | +26.1% | +15.6% |
| Lupin | Rs 8,407.21 crore | Rs 1,416.98 crore | +32.5% | +10.4% |
| FDC Limited | Rs 715.35 crore | Rs 132.49 crore | +4.6% | +12.7% |
Quarterly figures above are the most recent reported quarter for each company (Q1 FY28, quarter ended June 2026), compared with the year-ago and preceding quarter.
Download the Univest iOS App or Univest Android App to track Alembic Pharmaceuticals, Lupin and FDC Limited live prices.
What Should Investors Look at Beyond These Numbers?
Beyond the metrics above, investors comparing these three pharma formulations (fourth fresh set) names should track quarter-on-quarter revenue and margin trends, management commentary on demand and cost drivers, and any sector-specific regulatory developments, since a single-quarter snapshot can shift quickly.
Conclusion
Alembic Pharmaceuticals vs Lupin vs FDC Limited highlights how differently three companies in the same pharma formulations (fourth fresh set) segment can score across valuation, profitability and dividend metrics, even when operating in a similar space. This comparison does not declare a winner; investors should weigh these figures against their own research and risk appetite. Please read the disclaimer below before making any investment decision.
Disclaimer: Data and figures in this article are sourced from publicly available information as of September 2026 and may not reflect real-time prices. Please verify all data independently before making any investment decision. This comparison does not recommend or endorse any single stock over another; investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Alembic Pharmaceuticals vs Lupin vs FDC Limited
What is the market cap difference between Alembic Pharmaceuticals, Lupin and FDC Limited?
Ans. As of September 2026, Alembic Pharmaceuticals has a market cap of approximately Rs 16,698 crore, Lupin is at approximately Rs 95,939 crore, and FDC Limited is at approximately Rs 5,627 crore.
Which of the three has the highest PE ratio?
Ans. Among Alembic Pharmaceuticals, Lupin and FDC Limited, the PE ratios stand at 24.22, 17.28 and 19.23 respectively as of September 2026.
Which of the three has the highest ROE?
Ans. Alembic Pharmaceuticals, Lupin and FDC Limited post ROE of 11.89%, 23.76% and 11.32% respectively as of September 2026.
Which of these three stocks pays the highest dividend yield?
Ans. Alembic Pharmaceuticals, Lupin and FDC Limited carry dividend yields of 1.41%, 0.86% and 1.45% respectively.
What is the debt to equity ratio for Alembic Pharmaceuticals, Lupin and FDC Limited?
Ans. Alembic Pharmaceuticals carries a debt to equity of 0.25, Lupin of 0.29, and FDC Limited of 0.01.
Which of the three trades at the highest price to book value?
Ans. Alembic Pharmaceuticals, Lupin and FDC Limited trade at price to book ratios of 2.94, 4.27 and 2.26 respectively.
Is one of Alembic Pharmaceuticals, Lupin or FDC Limited better than the others?
Ans. This comparison does not declare one stock better than another; each company scores differently across valuation, profitability and dividend metrics, and the right fit depends on an individual investor’s own criteria and research.
